ID   PP161
AC   CVCL_C235
SY   PP 161; pp161
DR   cancercelllines; CVCL_C235
DR   Wikidata; Q54947770
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=19002021;
CC   Doubling time: 31.37 +- 11.49 hours (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Ter; Zygosity=Homozygous (PubMed=19002021).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=19002021; DOI=10.1097/MPA.0b013e31818c746a;
RA   Chifenti B., Morelli M., Zavaglia M., Coviello D.A., Guerneri S.,
RA   Santucci A., Paffetti A., Masetti M., Locci M.T., Bertacca G.,
RA   Capodanno A., Collecchi P., Campani D., Mosca F., Bevilacqua G.,
RA   Cavazzana A.O.;
RT   "Establishment and characterization of 4 new human pancreatic cancer
RT   cell lines: evidences of different tumor phenotypes.";
RL   Pancreas 38:184-196(2009).
//